Skip to main content

Delphine Kervella

Institutions of which they are part

Postdoctoral researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Delphine Kervella

Institutions of which they are part

Postdoctoral researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Projects

RESETTING THE IMMUNOLOGICAL SYSTEM OF HYPERSENSITIZED TRANSPLANT CANDIDATES TO ALLOW ACCESS TO HLA COMPATIBLE KIDNEY TRANSPLANTATION (RESET TRIAL)

IP: Oriol Bestard Matamoros
Collaborators: Ana Pérez González, RESETTING THE IMMUNOLOGICAL SYSTEM OF HYPERSENSITIZED TRANSPLANT CANDIDATES TO ALLOW ACCESS TO HLA COMPATIBLE KIDNEY TRANSPLANT, Elena Isabel Crespo Gimeno, Laura Donadeu Casassas, RESETTING THE IMMUNOLOGICAL SYSTEM OF HYPERSENSITIZED TRANSPLANT CANDIDATES TO ALLOW ACCESS TO HLA COMPATIBLE KIDNEY TRANSPLANT, Maria Antonia Emilia Meneghini, Delphine Kervella, Cristina Font Miñarro
Funding agency: Instituto de Salud Carlos III
Funding: 465456.69
Reference: ICI24/00066
Duration: 01/01/2025 - 31/12/2029

Cambios histológicos y transcripcionales en distintos fenotipos de Rechazo mediado por anticuerpos

IP: Irina Betsabe Torres Rodriguez
Collaborators: Francesc Moreso Mateos, Nestor Gabriel Toapanta Gaibor, Delphine Kervella
Funding agency: Instituto de Salud Carlos III
Funding: 96250
Reference: PI23/01909
Duration: 01/01/2024 - 31/12/2027

Immunological reset to overcome alloimmune memory in Highly sensitized patients

IP: Oriol Bestard Matamoros
Collaborators: Ana Pérez González, David Valcarcel Ferreiras, Francesc Bosch Albareda, Francesc Moreso Mateos, Enric Trilla Herrera, Joana Sellarés Roig, Irina Betsabe Torres Rodriguez, Elena Isabel Crespo Gimeno, Enric Miret Alomar, Manel Perelló Carrascosa, Nestor Gabriel Toapanta Gaibor, Maria Antonia Emilia Meneghini, Delphine Kervella
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 110000
Reference: FMM/ORIOL_BESTARD
Duration: 15/09/2023 - 15/09/2027

The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients

IP: Oriol Bestard Matamoros
Collaborators: Elena Isabel Crespo Gimeno, Delphine Kervella
Funding agency: EUROPEAN COMMISSION
Funding: 835583.76
Reference: EUTRAIN_H2020-SC12017
Duration: 01/01/2018 - 30/06/2024

Related news

Antibody-mediated rejection remains one of the leading causes of graft loss following kidney transplantation. A VHIR study investigating a novel therapeutic strategy to address this challenge has been recognized with the Young Investigator Award 2026.

The distinction from the Catalan Transplant Society will allow her to become a member of the Royal Academy of Medicine of Catalonia.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Maria Josefa Azpiroz Franch

Maria Josefa Azpiroz Franch

Predoctoral researcher
Cardiovascular Diseases
Read more
Elena Vargas Accarino

Elena Vargas Accarino

Postdoctoral researcher
Liver Diseases
Read more
Natalia Avani Da Silva

Natalia Avani Da Silva

Gestió i Administració
Communication Unit
Communication Directorate
Read more
Piero Arturo Alberti Delgado

Piero Arturo Alberti Delgado

Predoctoral researcher
General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.